Jasper Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SOLEUS CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 1.49 M | $6.43 M | 0.00% | 10.25% |
VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2025 | 1.43 M | $6.17 M | 0.00% | 9.83% |
CARLYLE GROUP INC. | 05/09/2025 | 1.07 M | $4.58 M | 0.00% | 7.31% |
BLACKROCK, INC. | 05/02/2025 | 787.61 K | $3.39 M | -2.53% | 5.40% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 702.76 K | $3.02 M | 755.30% | 4.82% |
VANGUARD GROUP INC | 05/09/2025 | 679.45 K | $2.92 M | -4.23% | 4.66% |
MORGAN STANLEY | 05/15/2025 | 653.98 K | $2.81 M | 8.13% | 4.48% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2025 | 575.00 K | $2.47 M | -11.54% | 3.94% |
FRANKLIN RESOURCES INC | 05/13/2025 | 534.71 K | $2.30 M | -7.75% | 3.67% |
UBS GROUP AG | 05/13/2025 | 534.64 K | $2.30 M | 225.37% | 3.67% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 05/15/2025 | 490.00 K | $2.11 M | 9.62% | 3.36% |
CITADEL ADVISORS LLC | 05/15/2025 | 375.17 K | $1.61 M | -11.44% | 2.57% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 360.69 K | $1.55 M | 25.59% | 2.47% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 263.68 K | $1.13 M | 2.33% | 1.81% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 233.76 K | $1.01 M | 11.15% | 1.60% |
STATE STREET CORP | 05/15/2025 | 227.88 K | $979.87 K | -1.06% | 1.56% |
DEUTSCHE BANK AG\ | 05/09/2025 | 169.35 K | $728.21 K | -0.79% | 1.16% |
LION POINT CAPITAL, LP | 05/15/2025 | 146.50 K | $629.95 K | 357.81% | 1.00% |
SPHERA FUNDS MANAGEMENT LTD. | 05/15/2025 | 122.02 K | $524.67 K | -10.10% | 0.84% |
NORTHERN TRUST CORP | 05/13/2025 | 103.09 K | $443.29 K | -1.22% | 0.71% |
05/12/2025 | 102.27 K | $439.75 K | 100.00% | 0.70% | |
BANK OF MONTREAL /CAN/ | 05/13/2025 | 71.74 K | $308.48 K | 100.00% | 0.49% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 44.66 K | $192.04 K | 18.45% | 0.31% |
VERITION FUND MANAGEMENT LLC | 05/15/2025 | 33.22 K | $142.84 K | 120.72% | 0.23% |
MARINER, LLC | 05/15/2025 | 31.19 K | $134.12 K | -15.23% | 0.21% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 26.65 K | $114.59 K | -17.59% | 0.18% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 25.94 K | $111.54 K | 100.00% | 0.18% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 25.11 K | $107.96 K | -54.44% | 0.17% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 25.03 K | $107.62 K | -0.20% | 0.17% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 23.70 K | $101.91 K | -46.50% | 0.16% |
CITADEL ADVISORS LLC | 05/15/2025 | 22.20 K | $95.46 K | 73.44% | 0.15% |
SOWELL FINANCIAL SERVICES LLC | 04/17/2025 | 20.83 K | $89.55 K | -25.74% | 0.14% |
SEI INVESTMENTS CO | 05/14/2025 | 18.85 K | $81.06 K | 100.00% | 0.13% |
BARCLAYS PLC | 05/15/2025 | 17.96 K | $77.00 K | -2.04% | 0.12% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 16.09 K | $69.19 K | -29.47% | 0.11% |
RHUMBLINE ADVISERS | 05/29/2025 | 15.59 K | $67.05 K | 5.64% | 0.11% |
FMR LLC | 05/12/2025 | 15.01 K | $64.56 K | -96.14% | 0.10% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 14.81 K | $63.67 K | 412.74% | 0.10% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 10.71 K | $46.00 K | 100.00% | 0.07% |
STATE OF WISCONSIN INVESTMENT BOARD | 05/15/2025 | 10.57 K | $45.46 K | -22.97% | 0.07% |
CITIGROUP INC | 05/12/2025 | 8.06 K | $34.65 K | -11.07% | 0.06% |
CITADEL ADVISORS LLC | 05/15/2025 | 8.00 K | $34.40 K | 433.33% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 6.83 K | $29.36 K | 4.79% | 0.05% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 6.11 K | $26.27 K | -17.60% | 0.04% |
COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 5.55 K | $23.85 K | -1.46% | 0.04% |
JPMORGAN CHASE & CO | 05/12/2025 | 5.54 K | $23.83 K | 7.28% | 0.04% |
NEW YORK STATE COMMON RETIREMENT FUND | 05/01/2025 | 4.60 K | $20.00 K | 0.00% | 0.03% |
CREWE ADVISORS LLC | 04/23/2025 | 3.10 K | $13.33 K | 100.00% | 0.02% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 2.49 K | $10.70 K | 60.00% | 0.02% |
05/09/2025 | 2.28 K | $9.79 K | 0.00% | 0.02% |
Jasper Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 91 institutional investors and hedge funds held shares of Jasper Therapeutics, Inc.. The most heavily invested institutionals were:
Soleus Capital Management, L.P.: 1.49 M
Velan Capital Investment Management LP: 1.43 M
Carlyle Group Inc.: 1.07 M
BlackRock, Inc.: 787,605
T. Rowe Price Investment Management, Inc.: 702,757
VANGUARD GROUP INC: 679,452
79.08% of Jasper Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 18.45 M shares in the last 24 months. This purchase volume represents approximately $94.49 M in transactions.